Health Condition 1: E282- Polycystic ovarian syndrome
Conditions
Interventions
None listed
Sponsors
Shree Dhootpapeshwar Ltd.
Eligibility
Inclusion criteria
Inclusion criteria: 1.Women in the age group of 18 - 45 years (both inclusive) with no conception 2.Women with the presence of any two of the three Rotterdam criteria: oligomenorrhoea, clinical hyperandrogenism, and polycystic ovarian morphology on ultra-sonography (USG) 3.Individuals willing to abide by the study-related procedures
Exclusion criteria
Exclusion criteria: 1.Known history of severe hepatic, renal, or cardiac pathologies viz. portal hypertension, nephropathy, oesophageal varices, myocardial infarction, stroke, arrythmia etc. 2.Known cases of active infections such as tuberculosis, HIV, or hepatitis B etc 3.Known history of congenital anomalies of genital tract, cervical pathologies such as polyp, Ca cervix, uterine pathologies such as fibroid, endometriosis 4.Known history of endocrinopathies such as hypothyroidism, hyperprolactinemia, Cushing’s Syndrome, adrenal tumor, ovarian tumor, and late-onset congenital adrenal hyperplasia 5.Women on anxiolytic, antipsychotic, and antidepressant drugs for the past 6 months 6.Any other conditions which in the opinion of investigator can place the patient at risk or can influence the conduct of study or interpretation of results
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.5% improvement in the insulin and glucose levels in Nishamlaki group comparable to Metformin group 2.Number of participants showing improvement in menstrual cycles comparable in both Nishamlaki and Metformin groups 3.5% improvement in anthropometry and body composition in Nishamlaki group comparable to Metformin group Timepoint: Baseline, day 30, day 60, day 90 | — |
Secondary
| Measure | Time frame |
|---|---|
| NoneTimepoint: NA | — |
Countries
India
Contacts
Public ContactDr Girija Wagh
Bharati Vidyapeeth Deemed to be University, Interactive Research School for Health Affairs IRSHA
Outcome results
None listed